+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Biosurgery Market 2021-2028

  • PDF Icon

    Report

  • 155 Pages
  • July 2021
  • Region: Asia Pacific
  • Triton Market Research
  • ID: 4774761

MARKET OUTLOOK

The publisher’s report suggests that the Asia-Pacific biosurgery market is probable to witness growth at a CAGR of 7.56% through the years 2021-2028. South Korea, Australia & New Zealand, India, ASEAN countries, Japan, China, and Rest of APAC form the market in this region.
In India, the rising burden of chronic diseases and the growing number of surgical procedures are key factors expected to augment the growth of the reviewed market during the estimated phase. For instance, in recent years, the number of patients suffering from cancer and cardiovascular diseases has increased. Moreover, as per estimates, the country is likely to witness an endemic of osteoarthritis in the next few years. This will ultimately enhance the demand for biosurgery products, in turn, offering new opportunities to the biosurgery market in India in the upcoming years.

Furthermore, over the years, there has been substantial growth in knee replacement procedures for osteoarthritis within Australia. This increase is estimated to amplify the demand for biosurgery products. Additionally, several new products are launched in the country, which will further support the growth of the studied market. Besides, the rise in the geriatric population and the emergence of several lifestyle conditions have also enhanced the demand for biosurgery products. Hence, all these factors are responsible for positioning the Australian biosurgery market on a growth path.

COMPETITIVE OUTLOOK

Some of the firms in the biosurgery market consist of Sanofi, Baxter International Inc, CSL Limited, Ethicon Inc (Johnson & Johnson), Integra Lifesciences Holdings Corporation, and Smith & Nephew Plc.

Table of Contents

1. Asia-Pacific Biosurgery Market - Summary
2. Industry Outlook
2.1. Impact of COVID-19 on Biosurgery Market
2.2. Trends in Biosurgery Technology
2.3. Key Insights
2.4. Porter's Five Forces Model
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute Products
2.4.3. Bargaining Power of Buyers
2.4.4. Bargaining Power of Suppliers
2.4.5. Competitive Rivalry
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Buying Outlook
2.8. Key Market Strategies
2.8.1. Contracts and Partnerships
2.8.2. Business Expansions, Announcements, & Divestitures
2.8.3. Acquisitions & Mergers
2.8.4. New Product Launches & Developments
2.9. Market Drivers
2.9.1. Growing Aging Population
2.9.2. Technological Advancements and Innovations in Healthcare Facilities
2.9.3. Surge in Surgical Treatments for Musculoskeletal Disorders
2.9.4. Prevalence of Spinal Fusion and Joint Reconstruction
2.9.5. Strong Focus on Research and Development
2.10. Market Challenges
2.10.1. High Cost of Surgeries
2.10.2. Complications Related to Immune Response
2.10.3. Usage of Minimally Invasive Surgeries
2.11. Market Opportunities
2.11.1. Research and Investments in Bioengineering
2.11.2. Development of Policies for Reimbursement and Compensation
3. Asia-Pacific Biosurgery Market - by Product
3.1. Hemostatic Agents
3.2. Bone-Graft Substitutes
3.2.1. Synthetic Graft Extenders
3.2.2. Demineralized Bone Matrix
3.2.3. Bone Morphogenetic Proteins
3.2.4. Cell-Based Matrices
3.3. Surgical Sealing Agents
3.3.1. Natural
3.3.2. Synthetic
3.4. Soft-Tissue Management
3.4.1. Synthetic Mesh/Patch
3.4.2. Natural Mesh/Patch
3.5. Anti-Adhesive Agents
3.6. Staple Line Reinforcement
4. Asia-Pacific Biosurgery Market - by Application
4.1. Orthopedic Surgery
4.2. Cardio and Thoracic Surgery
4.3. Neuro and Spine Surgery
4.4. General Surgery
4.5. Other Applications
5. Asia-Pacific Biosurgery Market - by Source Type
5.1. Natural
5.2. Synthetic
6. Asia-Pacific Biosurgery Market - Country Outlook
6.1. Country Analysis
6.1.1. China
6.1.2. Japan
6.1.3. India
6.1.4. Australia & New Zealand
6.1.5. South Korea
6.1.6. Asean Countries
6.1.7. Rest of Asia-Pacific
7. Competitive Landscape
7.1. Baxter International Inc
7.2. Becton, Dickinson and Company
7.3. B Braun Melsungen AG
7.4. Csl Limited
7.5. Ethicon Inc (Johnson & Johnson)
7.6. Integra Lifesciences Holdings Corporation
7.7. Medtronic plc
7.8. Rti Surgical
7.9. Sanofi
7.10. Smith & Nephew plc
7.11. Stryker Corporation
7.12. Wright Medical Group Nv
7.13. Zimmer Biomet Holdings Inc
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis
List of Tables
Table 1: Asia-Pacific Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Contracts and Partnerships
Table 4: Business Expansions, Announcements, & Divestitures
Table 5: Acquisitions & Mergers
Table 6: New Product Launches & Developments
Table 7: Asia-Pacific Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 8: Asia-Pacific Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 10: Asia-Pacific Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 11: Asia-Pacific Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 12: Asia-Pacific Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 13: Asia-Pacific Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
List of Figures
Figure 1: Asia-Pacific Biosurgery Market 2021-2028 (In $ Million)
Figure 2: Asia-Pacific Biosurgery Market, by Product, 2020 & 2028 (In %)
Figure 3: Asia-Pacific Biosurgery Market, by Hemostatic Agents, 2021-2028 (In $ Million)
Figure 4: Asia-Pacific Biosurgery Market, by Bone-Graft Substitutes, 2021-2028 (In $ Million)
Figure 5: Asia-Pacific Bone-Graft Substitutes Market, by Synthetic Graft Extenders, 2021-2028 (In $ Million)
Figure 6: Asia-Pacific Bone-Graft Substitutes Market, by Demineralized Bone Matrix, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Bone-Graft Substitutes Market, by Bone Morphogenetic Proteins, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Bone-Graft Substitutes Market, by Cell-Based Matrices, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Biosurgery Market, by Surgical Sealing Agents, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Surgical Sealing Agents Market, by Natural, 2021-2028 (In $ Million)
Figure 11: Asia-Pacific Surgical Sealing Agents Market, by Synthetic, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Biosurgery Market, by Soft-Tissue Management, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Soft-Tissue Management Market, by Synthetic Mesh/Patch, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Soft-Tissue Management Market, by Natural Mesh/Patch, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Biosurgery Market, by Anti-Adhesive Agents, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Biosurgery Market, by Staple Line Reinforcement, 2021-2028 (In $ Million)
Figure 17: Asia-Pacific Biosurgery Market, by Application, 2020 & 2028 (In %)
Figure 18: Asia-Pacific Biosurgery Market, by Orthopedic Surgery, 2021-2028 (In $ Million)
Figure 19: Asia-Pacific Biosurgery Market, by Cardio and Thoracic Surgery, 2021-2028 (In $ Million)
Figure 20: Asia-Pacific Biosurgery Market, by Neuro and Spine Surgery, 2021-2028 (In $ Million)
Figure 21: Asia-Pacific Biosurgery Market, by General Surgery, 2021-2028 (In $ Million)
Figure 22: Asia-Pacific Biosurgery Market, by Other Applications, 2021-2028 (In $ Million)
Figure 23: Asia-Pacific Biosurgery Market, by Source Type, 2020 & 2028 (In %)
Figure 24: Asia-Pacific Biosurgery Market, by Natural, 2021-2028 (In $ Million)
Figure 25: Asia-Pacific Biosurgery Market, by Synthetic, 2021-2028 (In $ Million)
Figure 26: China Biosurgery Market 2021-2028 (In $ Million)
Figure 27: Japan Biosurgery Market 2021-2028 (In $ Million)
Figure 28: India Biosurgery Market 2021-2028 (In $ Million)
Figure 29: Australia & New Zealand Biosurgery Market 2021-2028 (In $ Million)
Figure 30: South Korea Biosurgery Market 2021-2028 (In $ Million)
Figure 31: Asean Countries Biosurgery Market 2021-2028 (In $ Million)
Figure 32: Rest of Asia-Pacific Biosurgery Market 2021-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Baxter International Inc
  • Becton, Dickinson and Company
  • B Braun Melsungen AG
  • Csl Limited
  • Ethicon Inc (Johnson & Johnson)
  • Integra Lifesciences Holdings Corporation
  • Medtronic plc
  • Rti Surgical
  • Sanofi
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group Nv
  • Zimmer Biomet Holdings Inc

Methodology

Loading
LOADING...